Market Research Logo

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Targeted RNA Sequencing Market 2018, Forecast to 2023

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Targeted RNA Sequencing Market 2018, Forecast to 2023

Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.

Scope of the Report:
This report focuses on the Targeted RNA Sequencing in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.
Market competition is not intense. Thermo Fisher, Illumina, Roche Holdings, BGI, Eurofins, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The worldwide market for Targeted RNA Sequencing is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
Thermo Fisher
Illumina
Roche Holdings
BGI
Eurofins
LabCorp
Berry Genomics
Macrogen
GENEWIZ

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
enrichment approaches
amplicon-based approaches

Market Segment by Applications, can be divided into
Research Institutes
Hospitals & Clinics
Biotechnology Company
Diagnostic Lab

There are 15 Chapters to deeply display the global Targeted RNA Sequencing market.
Chapter 1, to describe Targeted RNA Sequencing Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Targeted RNA Sequencing, with sales, revenue, and price of Targeted RNA Sequencing, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Targeted RNA Sequencing, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Targeted RNA Sequencing market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Targeted RNA Sequencing sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source


1 Market Overview
1.1 Targeted RNA Sequencing Introduction
1.2 Market Analysis by Type
1.2.1 enrichment approaches
1.2.2 amplicon-based approaches
1.3 Market Analysis by Applications
1.3.1 Research Institutes
1.3.2 Hospitals & Clinics
1.3.3 Biotechnology Company
1.3.4 Diagnostic Lab
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Thermo Fisher
2.1.1 Business Overview
2.1.1.1 Thermo Fisher Description
2.1.1.2 Thermo Fisher Headquarter, Main Business and Finance Overview
2.1.2 Thermo Fisher Targeted RNA Sequencing Product Introduction
2.1.2.1 Targeted RNA Sequencing Production Bases, Sales Regions and Major Competitors
2.1.2.2 Targeted RNA Sequencing Product Information
2.1.3 Thermo Fisher Targeted RNA Sequencing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Thermo Fisher Targeted RNA Sequencing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Thermo Fisher Targeted RNA Sequencing Market Share in 2017
2.2 Illumina
2.2.1 Business Overview
2.2.1.1 Illumina Description
2.2.1.2 Illumina Headquarter, Main Business and Finance Overview
2.2.2 Illumina Targeted RNA Sequencing Product Introduction
2.2.2.1 Targeted RNA Sequencing Production Bases, Sales Regions and Major Competitors
2.2.2.2 Targeted RNA Sequencing Product Information
2.2.3 Illumina Targeted RNA Sequencing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Illumina Targeted RNA Sequencing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Illumina Targeted RNA Sequencing Market Share in 2017
2.3 Roche Holdings
2.3.1 Business Overview
2.3.1.1 Roche Holdings Description
2.3.1.2 Roche Holdings Headquarter, Main Business and Finance Overview
2.3.2 Roche Holdings Targeted RNA Sequencing Product Introduction
2.3.2.1 Targeted RNA Sequencing Production Bases, Sales Regions and Major Competitors
2.3.2.2 Targeted RNA Sequencing Product Information
2.3.3 Roche Holdings Targeted RNA Sequencing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Roche Holdings Targeted RNA Sequencing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Roche Holdings Targeted RNA Sequencing Market Share in 2017
2.4 BGI
2.4.1 Business Overview
2.4.1.1 BGI Description
2.4.1.2 BGI Headquarter, Main Business and Finance Overview
2.4.2 BGI Targeted RNA Sequencing Product Introduction
2.4.2.1 Targeted RNA Sequencing Production Bases, Sales Regions and Major Competitors
2.4.2.2 Targeted RNA Sequencing Product Information
2.4.3 BGI Targeted RNA Sequencing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 BGI Targeted RNA Sequencing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global BGI Targeted RNA Sequencing Market Share in 2017
2.5 Eurofins
2.5.1 Business Overview
2.5.1.1 Eurofins Description
2.5.1.2 Eurofins Headquarter, Main Business and Finance Overview
2.5.2 Eurofins Targeted RNA Sequencing Product Introduction
2.5.2.1 Targeted RNA Sequencing Production Bases, Sales Regions and Major Competitors
2.5.2.2 Targeted RNA Sequencing Product Information
2.5.3 Eurofins Targeted RNA Sequencing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Eurofins Targeted RNA Sequencing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Eurofins Targeted RNA Sequencing Market Share in 2017
2.6 LabCorp
2.6.1 Business Overview
2.6.1.1 LabCorp Description
2.6.1.2 LabCorp Headquarter, Main Business and Finance Overview
2.6.2 LabCorp Targeted RNA Sequencing Product Introduction
2.6.2.1 Targeted RNA Sequencing Production Bases, Sales Regions and Major Competitors
2.6.2.2 Targeted RNA Sequencing Product Information
2.6.3 LabCorp Targeted RNA Sequencing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 LabCorp Targeted RNA Sequencing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global LabCorp Targeted RNA Sequencing Market Share in 2017
2.7 Berry Genomics
2.7.1 Business Overview
2.7.1.1 Berry Genomics Description
2.7.1.2 Berry Genomics Headquarter, Main Business and Finance Overview
2.7.2 Berry Genomics Targeted RNA Sequencing Product Introduction
2.7.2.1 Targeted RNA Sequencing Production Bases, Sales Regions and Major Competitors
2.7.2.2 Targeted RNA Sequencing Product Information
2.7.3 Berry Genomics Targeted RNA Sequencing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Berry Genomics Targeted RNA Sequencing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Berry Genomics Targeted RNA Sequencing Market Share in 2017
2.8 Macrogen
2.8.1 Business Overview
2.8.1.1 Macrogen Description
2.8.1.2 Macrogen Headquarter, Main Business and Finance Overview
2.8.2 Macrogen Targeted RNA Sequencing Product Introduction
2.8.2.1 Targeted RNA Sequencing Production Bases, Sales Regions and Major Competitors
2.8.2.2 Targeted RNA Sequencing Product Information
2.8.3 Macrogen Targeted RNA Sequencing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Macrogen Targeted RNA Sequencing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Macrogen Targeted RNA Sequencing Market Share in 2017
2.9 GENEWIZ
2.9.1 Business Overview
2.9.1.1 GENEWIZ Description
2.9.1.2 GENEWIZ Headquarter, Main Business and Finance Overview
2.9.2 GENEWIZ Targeted RNA Sequencing Product Introduction
2.9.2.1 Targeted RNA Sequencing Production Bases, Sales Regions and Major Competitors
2.9.2.2 Targeted RNA Sequencing Product Information
2.9.3 GENEWIZ Targeted RNA Sequencing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 GENEWIZ Targeted RNA Sequencing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global GENEWIZ Targeted RNA Sequencing Market Share in 2017
3 Global Targeted RNA Sequencing Market Competition, by Manufacturer
3.1 Global Targeted RNA Sequencing Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Targeted RNA Sequencing Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Targeted RNA Sequencing Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Targeted RNA Sequencing Manufacturer Market Share in 2017
3.4.2 Top 5 Targeted RNA Sequencing Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Targeted RNA Sequencing Market Analysis by Regions
4.1 Global Targeted RNA Sequencing Sales, Revenue and Market Share by Regions
4.1.1 Global Targeted RNA Sequencing Sales by Regions (2013-2018)
4.1.2 Global Targeted RNA Sequencing Revenue by Regions (2013-2018)
4.2 North America Targeted RNA Sequencing Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Targeted RNA Sequencing Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Targeted RNA Sequencing Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Targeted RNA Sequencing Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Targeted RNA Sequencing Sales, Revenue and Growth Rate (2013-2018)
5 North America Targeted RNA Sequencing by Countries, Type, Application and Manufacturers
5.1 North America Targeted RNA Sequencing Sales, Revenue and Market Share by Countries
5.1.1 North America Targeted RNA Sequencing Sales by Countries (2013-2018)
5.1.2 North America Targeted RNA Sequencing Revenue by Countries (2013-2018)
5.1.3 United States Targeted RNA Sequencing Sales and Growth Rate (2013-2018)
5.1.4 Canada Targeted RNA Sequencing Sales and Growth Rate (2013-2018)
5.1.5 Mexico Targeted RNA Sequencing Sales and Growth Rate (2013-2018)
5.2 North America Targeted RNA Sequencing Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Targeted RNA Sequencing Sales by Manufacturers (2016-2017)
5.2.2 North America Targeted RNA Sequencing Revenue by Manufacturers (2016-2017)
5.3 North America Targeted RNA Sequencing Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Targeted RNA Sequencing Sales and Sales Share by Type (2013-2018)
5.3.2 North America Targeted RNA Sequencing Revenue and Revenue Share by Type (2013-2018)
5.4 North America Targeted RNA Sequencing Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Targeted RNA Sequencing Sales and Sales Share by Application (2013-2018)
5.4.2 North America Targeted RNA Sequencing Revenue and Revenue Share by Application (2013-2018)
6 Europe Targeted RNA Sequencing by Countries, Type, Application and Manufacturers
6.1 Europe Targeted RNA Sequencing Sales, Revenue and Market Share by Countries
6.1.1 Europe Targeted RNA Sequencing Sales by Countries (2013-2018)
6.1.2 Europe Targeted RNA Sequencing Revenue by Countries (2013-2018)
6.1.3 Germany Targeted RNA Sequencing Sales and Growth Rate (2013-2018)
6.1.4 UK Targeted RNA Sequencing Sales and Growth Rate (2013-2018)
6.1.5 France Targeted RNA Sequencing Sales and Growth Rate (2013-2018)
6.1.6 Russia Targeted RNA Sequencing Sales and Growth Rate (2013-2018)
6.1.7 Italy Targeted RNA Sequencing Sales and Growth Rate (2013-2018)
6.2 Europe Targeted RNA Sequencing Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Targeted RNA Sequencing Sales by Manufacturers (2016-2017)
6.2.2 Europe Targeted RNA Sequencing Revenue by Manufacturers (2016-2017)
6.3 Europe Targeted RNA Sequencing Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Targeted RNA Sequencing Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Targeted RNA Sequencing Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Targeted RNA Sequencing Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Targeted RNA Sequencing Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Targeted RNA Sequencing Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Targeted RNA Sequencing by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Targeted RNA Sequencing Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Targeted RNA Sequencing Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Targeted RNA Sequencing Revenue by Countries (2013-2018)
7.1.3 China Targeted RNA Sequencing Sales and Growth Rate (2013-2018)
7.1.4 Japan Targeted RNA Sequencing Sales and Growth Rate (2013-2018)
7.1.5 Korea Targeted RNA Sequencing Sales and Growth Rate (2013-2018)
7.1.6 India Targeted RNA Sequencing Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Targeted RNA Sequencing Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Targeted RNA Sequencing Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Targeted RNA Sequencing Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Targeted RNA Sequencing Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Targeted RNA Sequencing Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Targeted RNA Sequencing Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Targeted RNA Sequencing Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Targeted RNA Sequencing Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Targeted RNA Sequencing Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Targeted RNA Sequencing Revenue and Revenue Share by Application (2013-2018)
8 South America Targeted RNA Sequencing by Countries, Type, Application and Manufacturers
8.1 South America Targeted RNA Sequencing Sales, Revenue and Market Share by Countries
8.1.1 South America Targeted RNA Sequencing Sales by Countries (2013-2018)
8.1.2 South America Targeted RNA Sequencing Revenue by Countries (2013-2018)
8.1.3 Brazil Targeted RNA Sequencing Sales and Growth Rate (2013-2018)
8.1.4 Argentina Targeted RNA Sequencing Sales and Growth Rate (2013-2018)
8.1.5 Colombia Targeted RNA Sequencing Sales and Growth Rate (2013-2018)
8.2 South America Targeted RNA Sequencing Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Targeted RNA Sequencing Sales by Manufacturers (2016-2017)
8.2.2 South America Targeted RNA Sequencing Revenue by Manufacturers (2016-2017)
8.3 South America Targeted RNA Sequencing Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Targeted RNA Sequencing Sales and Sales Share by Type (2013-2018)
8.3.2 South America Targeted RNA Sequencing Revenue and Revenue Share by Type (2013-2018)
8.4 South America Targeted RNA Sequencing Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Targeted RNA Sequencing Sales and Sales Share by Application (2013-2018)
8.4.2 South America Targeted RNA Sequencing Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Targeted RNA Sequencing by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Targeted RNA Sequencing Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Targeted RNA Sequencing Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Targeted RNA Sequencing Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Targeted RNA Sequencing Sales and Growth Rate (2013-2018)
9.1.4 UAE Targeted RNA Sequencing Sales and Growth Rate (2013-2018)
9.1.5 Egypt Targeted RNA Sequencing Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Targeted RNA Sequencing Sales and Growth Rate (2013-2018)
9.1.7 South Africa Targeted RNA Sequencing Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Targeted RNA Sequencing Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Targeted RNA Sequencing Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Targeted RNA Sequencing Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Targeted RNA Sequencing Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Targeted RNA Sequencing Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Targeted RNA Sequencing Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Targeted RNA Sequencing Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Targeted RNA Sequencing Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Targeted RNA Sequencing Revenue and Revenue Share by Application (2013-2018)
10 Global Targeted RNA Sequencing Market Segment by Type
10.1 Global Targeted RNA Sequencing Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Targeted RNA Sequencing Sales and Market Share by Type (2013-2018)
10.1.2 Global Targeted RNA Sequencing Revenue and Market Share by Type (2013-2018)
10.2 enrichment approaches Sales Growth and Price
10.2.1 Global enrichment approaches Sales Growth (2013-2018)
10.2.2 Global enrichment approaches Price (2013-2018)
10.3 amplicon-based approaches Sales Growth and Price
10.3.1 Global amplicon-based approaches Sales Growth (2013-2018)
10.3.2 Global amplicon-based approaches Price (2013-2018)
11 Global Targeted RNA Sequencing Market Segment by Application
11.1 Global Targeted RNA Sequencing Sales Market Share by Application (2013-2018)
11.2 Research Institutes Sales Growth (2013-2018)
11.3 Hospitals & Clinics Sales Growth (2013-2018)
11.4 Biotechnology Company Sales Growth (2013-2018)
11.5 Diagnostic Lab Sales Growth (2013-2018)
12 Targeted RNA Sequencing Market Forecast (2018-2023)
12.1 Global Targeted RNA Sequencing Sales, Revenue and Growth Rate (2018-2023)
12.2 Targeted RNA Sequencing Market Forecast by Regions (2018-2023)
12.2.1 North America Targeted RNA Sequencing Market Forecast (2018-2023)
12.2.2 Europe Targeted RNA Sequencing Market Forecast (2018-2023)
12.2.3 Asia-Pacific Targeted RNA Sequencing Market Forecast (2018-2023)
12.2.4 South America Targeted RNA Sequencing Market Forecast (2018-2023)
12.2.5 Middle East and Africa Targeted RNA Sequencing Market Forecast (2018-2023)
12.3 Targeted RNA Sequencing Market Forecast by Type (2018-2023)
12.3.1 Global Targeted RNA Sequencing Sales Forecast by Type (2018-2023)
12.3.2 Global Targeted RNA Sequencing Market Share Forecast by Type (2018-2023)
12.4 Targeted RNA Sequencing Market Forecast by Application (2018-2023)
12.4.1 Global Targeted RNA Sequencing Sales Forecast by Application (2018-2023)
12.4.2 Global Targeted RNA Sequencing Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report